ConductScience.org, home

Paper46777

Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts.

Krishan A and 1 other. Cancer Res, 1975. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts. Papers, record 46777. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/46777

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts.
PubMed
Journal
Cancer Res
PubMed
Year
1975
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
2.03
iCite
Revised in PubMed
2015-11-19
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Krishan AA
2Frei E 3rdE

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, LymphoidMajor topic
LymphocytesMajor topic
VinblastineMajor topic
VincristineMajor topic
Bleomycin
Cell Line
Doxorubicin
Humans

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
27620987Microtubule destabilising agents: far more than just antimitotic anticancer drugs.Br J Clin Pharmacol2017https://conductscience.org/library/papers/27620987PubMed
8104946Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine.J Cancer Res Clin Oncol1993https://conductscience.org/library/papers/8104946PubMed
6713514In vivo shedding of apical plasma membrane in the thyroid follicle cells of the mouse.Cell Tissue Res1984https://conductscience.org/library/papers/6713514PubMed
6189661Clinical pharmacokinetics of commonly used anticancer drugs.Clin Pharmacokinet1983https://conductscience.org/library/papers/6189661PubMed
4066762Cell surface tubulin in leukemic cells: molecular structure, surface binding, turnover, cell cycle expression, and origin.J Cell Biol1985https://conductscience.org/library/papers/4066762PubMed
993346The effects of colcemid on hematopoiesis in the mouse.J Clin Invest1976https://conductscience.org/library/papers/993346PubMed
889685Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation.Br J Cancer1977https://conductscience.org/library/papers/889685PubMed
588443Electron microscopy on the effect of vinblastine on the telencephalic wall of the rat fetus.Br J Exp Pathol1977https://conductscience.org/library/papers/588443PubMed
324507Ultrastructure of cell surface abnormalities in neoplastic histiocytes.Br J Cancer1977https://conductscience.org/library/papers/324507PubMed
268292Ropalocytosis in acute leukemia.Experientia1977https://conductscience.org/library/papers/268292PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/46777

GET https://conductscience.org/api/papers/v1/46777/authors